U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Morbidity and Mortality Weekly Report (MMWR)

CDC Stacks Public Health Publications

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

(45)
(67)
(184)
(229)
(500)
(673)
(659)
(403)
(489)
(557)
(246)
(325)
(427)
(406)
(97)
(156)
(103)
(110)
(97)
(92)
(119)
(92)
(108)
(96)
(97)
(92)
(79)
(97)
(87)
(91)
(88)
(76)
(74)
(84)
(80)
(69)
(70)
(73)
(68)
(69)
(59)
(67)
(62)
(64)
(62)
(66)
(72)
(55)
(53)
(55)
(60)
(56)
(58)
(54)
(53)
(56)
(55)
(52)
(54)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(51)
0 of 75
(44)
(63)
(187)
(222)
(500)
(663)
(656)
(409)
(483)
(558)
(231)
(311)
(436)
(413)
(91)
(148)
(100)
(104)
(102)
(92)
(120)
(92)
(104)
(97)
(97)
(91)
(80)
(97)
(86)
(90)
(87)
(76)
(75)
(84)
(80)
(69)
(69)
(71)
(69)
(64)
(60)
(68)
(62)
(62)
(62)
(67)
(72)
(56)
(55)
(54)
(59)
(57)
(58)
(54)
(53)
(55)
(55)
(55)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
0 of 75
(1)
(7)
(33)
(71)
(44)
(137)
(157)
(161)
(151)
(137)
(163)
(169)
(155)
(160)
(161)
(157)
(163)
(164)
(156)
(164)
(156)
(173)
(142)
(155)
(159)
(134)
(156)
(141)
(142)
(141)
(137)
(138)
(142)
(131)
(162)
(144)
(136)
(152)
(152)
(177)
(206)
(197)
(164)
(187)
(179)
(201)
(205)
(202)
(223)
(225)
(232)
(221)
(225)
(252)
(252)
(277)
0 of 56
(2)
(1)
(4)
(1)
(431)
(107)
(405)
(13)
(8547)
0 of 9
(16)
(34)
(37)
(4)
(1)
(2)
(6)
(1)
0 of 8
(10)
(10)
(25)
(11)
(7)
(20)
(27)
(42)
(58)
(7)
(23)
(13)
(7)
(38)
(10)
(10)
(50)
(7)
(33)
(1236)
(23)
(1293)
(32)
(71)
(10)
(91)
(26)
(16)
(7)
(791)
(198)
(24)
(128)
(70)
(39)
(61)
(10)
(9)
(11)
(17)
(20)
(38)
(19)
(26)
(15)
(26)
(9)
(11)
(17)
(10)
(7)
(48)
(11)
(8)
(223)
(17)
(17)
(8)
(181)
(137)
(129)
(32)
(8)
(15)
(13)
(9)
(10)
(13)
(15)
(9)
(15)
(8)
(29)
(17)
(10)
(7)
(18)
(100)
(13)
(12)
(36)
(18)
(8)
(12)
(7)
(11)
(11)
(30)
(9)
(9)
(9)
(15)
(21)
(8)
(17)
(7)
(8)
(31)
(77)
(10)
(61)
(7)
(7)
(14)
(12)
(13)
(15)
(19)
(85)
(13)
(11)
(14)
(31)
(14)
(13)
(30)
(28)
(12)
(187)
(7)
(7)
(17)
(8)
(18)
(53)
(11)
(7)
(17)
(22)
(20)
(7)
(15)
(10)
(9)
(24)
(13)
(31)
(20)
(29)
(7)
(13)
(13)
(31)
(73)
(10)
(21)
(24)
(8)
(26)
(20)
(7)
(7)
(8)
(13)
(28)
(25)
(9)
(940)
(740)
(9)
(14)
(7)
(14)
(35)
(7)
(103)
(10)
(51)
(10)
(19)
(11)
(11)
(9)
(58)
(12)
(20)
(14)
(49)
(20)
(21)
(19)
(20)
(16)
(177)
(80)
(2979)
(37)
(12)
(546)
(316)
(260)
(215)
(24)
(38)
(14)
(15)
(14)
(12)
(34)
(10)
(80)
(14)
(11)
(8)
(23)
(8)
(8)
(28)
(446)
(21)
(23)
(15)
(8)
(74)
(25)
(19)
(9)
(18)
(18)
(18)
(45)
(687)
(8)
(10)
(15)
(59)
(205)
(7)
(10)
(18)
(8)
(12)
(66)
(24)
(14)
(40)
(73)
(8)
(11)
(8)
(11)
(20)
(19)
(23)
(58)
(9)
(8)
(16)
(33)
(44)
(82)
(9)
(10)
(8)
(21)
(65)
(8)
(13)
(14)
(28)
(25)
(14)
(10)
(10)
(8)
(166)
(24)
(14)
(35)
(26)
(9)
(11)
(9)
(24)
(26)
(12)
(92)
(4170)
(636)
(34)
(12)
(17)
(10)
(14)
(11)
(12)
(13)
(9)
(28)
(16)
(19)
(8)
(8)
(12)
(27)
(17)
(14)
(44)
(20)
(28)
(36)
(10)
(20)
(8)
(21)
(8)
(66)
(91)
(24)
(9)
(27)
(13)
(21)
(22)
(8)
(39)
(56)
(68)
(21)
(15)
(149)
(8)
(12)
(32)
(16)
(14)
(19)
(19)
(16)
(22)
(10)
(11)
(144)
(45)
(32)
(9)
(41)
(32)
(15)
(654)
(51)
(26)
(9)
(56)
(14)
(130)
(9)
(18)
(62)
(8)
(10)
(10)
(30)
(11)
(10)
(13)
(21)
(8)
(15)
(23)
(111)
(23)
(1338)
(14)
(10)
(17)
(11)
(13)
(8)
(8)
(48)
(8)
(25)
(186)
(14)
(42)
(45)
(25)
(47)
(13)
(16)
(11)
(593)
(394)
(15)
(21)
(14)
(152)
(15)
(53)
(9)
(28)
(10)
(19)
(11)
(8)
(8)
(110)
(10)
(78)
(11)
(52)
(68)
(59)
(17)
(23)
(60)
(132)
(19)
(105)
(58)
(12)
(39)
(126)
(35)
(97)
(17)
(10)
(11)
(12)
(12)
(8)
(14)
(52)
(69)
(116)
(29)
(172)
(25)
(17)
(50)
(12)
(10)
(33)
(12)
(10)
(45)
(11)
(8)
(8)
(60)
(31)
(90)
(44)
(19)
(159)
(10)
(14)
(31)
(8)
(8)
(9)
(9)
(12)
(28)
(51)
(9)
(206)
(18)
(31)
(17)
(19)
(2445)
(16)
(18)
(18)
(11)
(104)
(20)
(38)
(8)
(206)
(231)
(23)
(8)
(8)
(9)
(18)
(240)
(11)
(49)
(678)
(10)
(307)
(15)
(47)
(61)
(23)
(17)
(8)
(21)
(595)
(13)
(61)
(15)
(14)
(9)
(37)
(26)
(22)
(29)
(188)
(45)
(54)
(48)
(8)
(114)
(50)
(10)
(125)
(28)
(11)
(12)
(8)
(32)
(22)
(8)
(12)
(8)
(22)
(13)
(61)
(16)
(11)
(10)
(73)
(9)
(10)
(10)
(74)
(32)
(114)
(9)
(13)
(41)
(17)
(55)
(17)
(13)
(16)
(18)
(10)
(17)
(44)
(66)
(10)
(11)
(9)
(10)
(177)
(17)
(12)
(14)
(1181)
(9)
(9)
(8)
(50)
(10)
(44)
(109)
(10)
(16)
(8)
(19)
(308)
(40)
(33)
(23)
(11)
(12)
(9)
(83)
(11)
(12)
(18)
(20)
(8)
(11)
(8)
(8)
(19)
(58)
(32)
(82)
(14)
(37)
(8)
(21)
(40)
(13)
(17)
(17)
(9)
(9)
(66)
(19)
(963)
(103)
(15)
(48)
(30)
(12)
(8)
(10)
(57)
(3831)
(11)
(9)
(9)
(31)
(16)
(21)
(16)
(16)
(15)
(17)
(10)
(13)
(8)
(8)
(11)
(18)
(9)
(14)
(15)
(9)
(16)
(41)
(43)
(20)
(10)
(27)
(11)
(12)
(10)
(15)
(243)
(18)
(22)
(8)
(36)
(14)
(113)
(10)
(257)
(611)
(72)
(11)
(21)
(17)
(8)
(11)
(15)
(9)
(10)
(299)
(12)
(10)
(8)
(14)
(11)
(12)
(11)
(20)
(10)
(10)
(16)
(13)
(13)
(10)
(22)
(10)
(65)
(10)
(9)
(10)
(9)
(9)
(19)
(12)
(9)
(144)
(18)
(14)
(8)
(33)
(144)
(11)
(171)
(10)
(8)
(8)
(22)
(70)
(343)
(114)
(84)
(24)
(36)
(34)
(11)
(30)
(14)
(8)
(10)
(25)
(21)
(29)
(21)
(18)
(16)
(1141)
(18)
(27)
(18)
(22)
(110)
(15)
(22)
(23)
(349)
(10)
(18)
(72)
(16)
(15)
(26)
(14)
(27)
(35)
(10)
(9)
(11)
(216)
(50)
(16)
(23)
(34)
(21)
(10)
(19)
(74)
(20)
(9)
(233)
(1003)
(22)
(24)
(71)
(101)
(2518)
(11)
(104)
(12)
(23)
(15)
(16)
(14)
(93)
(177)
(38)
(279)
(15)
(8)
(9)
(13)
(45)
(32)
(91)
(9)
(17)
(18)
(16)
(23)
(71)
(37)
(18)
(12)
(8)
(12)
(21)
(10)
(28)
(10)
(10)
(8)
(24)
(104)
(187)
(28)
(29)
(25)
(10)
(20)
(9)
(58)
(67)
(195)
(303)
(8)
(14)
(11)
(21)
(12)
(8)
(58)
(17)
(34)
(9)
(38)
(617)
(31)
(32)
(146)
(241)
(12)
(177)
(10)
(18)
(10)
(122)
(8)
(11)
(126)
(9)
(16)
(18)
(15)
(20)
(11)
(9)
(19)
(11)
(28)
(35)
(38)
(11)
(8)
(65)
(22)
(16)
(40)
(28)
(10)
(14)
(10)
(14)
(12)
(80)
(31)
(8)
(39)
(9)
(20)
(18)
(12)
(184)
(9)
(28)
(23)
(70)
(25)
(23)
(25)
(14)
(8)
(9)
(108)
(8)
(22)
(16)
(44)
(16)
(134)
(51)
(10)
(19)
(10)
(56)
(9)
(8)
(12)
(18)
(94)
(35)
(31)
(12)
(49)
(8)
(38)
(91)
(9)
(22)
(14)
(182)
(10)
(8)
(8)
(19)
(33)
(21)
(19)
(12)
(8)
(69)
(9)
(8)
(54)
(15)
(12)
(8)
(15)
(8)
(10)
(58)
(19)
(181)
(28)
(36)
(22)
(106)
(19)
(157)
(13)
(9)
(12)
(15)
(68)
(9)
(14)
(182)
(10)
(10)
(19)
(70)
(18)
(29)
(17)
(50)
(17)
(19)
(9)
(14)
(464)
(11)
(48)
(49)
(104)
(17)
(102)
(29)
(25)
(34)
(21)
(40)
(8)
(10)
(23)
(31)
(20)
(35)
(21)
(12)
(18)
(8)
(43)
(94)
(22)
(26)
(9)
(23)
(9)
(12)
(8)
(39)
(14)
(14)
(59)
(11)
(9)
(38)
(17)
(16)
(39)
(15)
(78)
(8)
(10)
(43)
(13)
(15)
(46)
(27)
(763)
(30)
(57)
(10)
(12)
(29)
0 of 1000
(12)
(12)
(15)
(7)
(23)
(9)
(7)
(18)
(8)
(7)
(10)
(11)
(7)
(9)
(7)
(10)
(9)
(11)
(11)
(19)
(9)
(11)
(9)
(10)
(27)
(8)
(9)
(12)
(23)
(15)
(9)
(7)
(7)
(7)
(9)
(13)
(11)
(9)
(15)
(7)
(7)
(7)
(7)
(9)
(8)
(19)
(9)
(9)
(7)
(7)
(13)
(7)
(7)
(9)
(7)
(9)
(7)
(16)
(13)
(7)
(12)
(12)
(22)
(28)
(15)
(8)
(8)
(13)
(7)
(19)
(12)
(12)
(13)
(15)
(16)
(9)
(10)
(7)
(11)
(28)
(7)
(13)
(28)
(7)
(10)
(11)
(11)
(13)
(10)
(8)
(18)
(9)
(10)
(16)
(29)
(8)
(12)
(12)
(13)
(8)
(9)
(7)
(28)
(9)
(16)
(7)
(29)
(7)
(8)
(8)
(11)
(16)
(16)
(12)
(35)
(8)
(11)
(16)
(18)
(9)
(29)
(9)
(14)
(22)
(31)
(11)
(7)
(7)
(10)
(7)
(18)
(9)
(7)
(9)
(7)
(7)
(7)
(11)
(9)
(23)
(20)
(10)
(7)
(7)
(15)
(10)
(8)
(37)
(8)
(22)
(10)
(16)
(11)
(10)
(24)
(13)
(7)
(11)
(7)
(9)
(11)
(9)
(12)
(21)
(9)
(9)
(7)
(11)
(7)
(16)
(9)
(7)
(9)
(12)
(19)
(12)
(7)
(7)
(7)
(11)
(10)
(7)
(9)
(24)
(7)
(8)
(10)
(12)
(8)
(13)
(25)
(23)
(7)
(24)
(16)
(9)
(7)
(10)
(9)
(8)
(8)
(13)
(9)
(9)
(10)
(7)
(10)
(7)
(20)
(8)
(9)
(7)
(18)
(17)
(11)
(10)
(12)
(9)
(12)
(7)
(9)
(7)
(9)
(8)
(15)
(8)
(8)
(13)
(28)
(7)
(18)
(8)
(12)
(15)
(7)
(7)
(17)
(17)
(8)
(16)
(8)
(20)
(7)
(8)
(11)
(11)
(21)
(8)
(11)
(10)
(13)
(9)
(8)
(7)
(12)
(8)
(15)
(9)
(11)
(7)
(17)
(12)
(17)
(16)
(7)
(18)
(24)
(11)
(7)
(7)
(12)
(8)
(19)
(20)
(16)
(11)
(12)
(7)
(8)
(10)
(14)
(16)
(7)
(9)
(11)
(20)
(15)
(9)
(16)
(48)
(9)
(11)
(24)
(11)
(8)
(9)
(7)
(10)
(9)
(7)
(10)
(8)
(53)
(13)
(9)
(11)
(15)
(42)
(16)
(8)
(8)
(29)
(10)
(7)
(10)
(8)
(8)
(24)
(8)
(11)
(12)
(8)
(13)
(21)
(24)
(10)
(10)
(16)
(20)
(11)
(10)
(15)
(17)
(12)
(18)
(7)
(17)
(16)
(10)
(15)
(18)
(14)
(16)
(22)
(7)
(9)
(17)
(12)
(15)
(8)
(18)
(20)
(15)
(11)
(29)
(7)
(10)
(23)
(7)
(7)
(27)
(8)
(7)
(26)
(18)
(8)
(12)
(11)
(8)
(36)
(15)
(12)
(7)
(8)
(15)
(16)
(7)
(7)
(9)
(10)
(9)
(17)
(7)
(12)
(12)
(13)
(12)
(16)
(9)
(13)
(8)
(15)
(24)
(8)
(8)
(8)
(7)
(17)
(9)
(7)
(28)
(12)
(15)
(13)
(9)
(7)
(7)
(9)
(8)
(7)
(8)
(14)
(9)
(14)
(17)
(7)
(8)
(7)
(10)
(11)
(7)
(16)
(9)
(59)
(12)
(8)
(8)
(7)
(7)
(9)
(7)
(18)
(7)
(8)
(18)
(9)
(15)
(10)
(8)
(25)
(11)
(8)
(9)
(14)
(26)
(23)
(8)
(43)
(11)
(14)
(7)
(15)
(11)
(20)
(7)
(28)
(15)
(10)
(9)
(25)
(18)
(7)
(8)
(8)
(7)
(18)
(15)
(15)
(11)
(7)
(8)
(7)
(10)
(14)
(8)
(30)
(15)
(7)
(9)
(19)
(18)
(15)
(9)
(7)
(7)
(8)
(13)
(11)
(15)
(17)
(8)
(49)
(7)
(32)
(13)
(10)
(16)
(7)
(23)
(24)
(9)
(10)
(25)
(8)
(20)
(7)
(7)
(13)
(7)
(11)
(9)
(7)
(7)
(10)
(9)
(8)
(9)
(7)
(7)
(10)
(16)
(14)
(12)
(7)
(10)
(20)
(9)
(15)
(7)
(7)
(11)
(12)
(11)
(13)
(8)
(7)
(19)
(26)
(17)
(7)
(15)
(9)
(8)
(18)
(17)
(8)
(8)
(12)
(7)
(10)
(7)
(9)
(8)
(18)
(18)
(11)
(8)
(35)
(21)
(7)
(7)
(18)
(9)
(7)
(10)
(7)
(10)
(9)
(14)
(14)
(10)
(24)
(12)
(8)
(53)
(7)
(7)
(7)
(19)
(8)
(10)
(10)
(8)
(10)
(7)
(9)
(8)
(8)
(20)
(13)
(27)
(8)
(8)
(19)
(7)
(19)
(7)
(11)
(7)
(12)
(7)
(11)
(11)
(28)
(10)
(9)
(7)
(20)
(10)
(13)
(7)
(8)
(9)
(13)
(11)
(10)
(7)
(13)
(9)
(7)
(10)
(8)
(7)
(7)
(10)
(14)
(9)
(38)
(23)
(10)
(8)
(7)
(10)
(11)
(10)
(13)
(15)
(10)
(7)
(17)
(10)
(7)
(7)
(11)
(11)
(12)
(8)
(10)
(18)
(14)
(8)
(10)
(21)
(16)
(14)
(14)
(9)
(15)
(9)
(19)
(24)
(11)
(20)
(21)
(16)
(7)
(7)
(10)
(23)
(7)
(8)
(17)
(7)
(9)
(10)
(7)
(7)
(17)
(8)
(8)
(7)
(9)
(9)
(13)
(10)
(8)
(13)
(9)
(13)
(8)
(18)
(7)
(7)
(27)
(12)
(8)
(15)
(9)
(17)
(8)
(18)
(7)
(26)
(12)
(9)
(11)
(22)
(7)
(10)
(7)
(7)
(13)
(7)
(7)
(8)
(10)
(21)
(15)
(14)
(35)
(18)
(7)
(7)
(7)
(8)
(21)
(16)
(24)
(24)
(18)
(8)
(7)
(18)
(12)
(7)
(7)
(13)
(25)
(7)
(8)
(12)
(11)
(19)
(7)
(27)
(18)
(10)
(10)
(8)
(12)
(7)
(7)
(7)
(10)
(7)
(7)
(10)
(16)
(12)
(10)
(7)
(18)
(7)
(25)
(10)
(15)
(10)
(18)
(24)
(13)
(16)
(9)
(19)
(13)
(26)
(16)
(18)
(8)
(10)
(8)
(10)
(14)
(7)
(10)
(7)
(13)
(7)
(7)
(11)
(17)
(15)
(13)
(13)
(13)
(8)
(33)
(8)
(11)
(11)
(8)
(11)
(12)
(21)
(10)
(9)
(12)
(23)
(8)
(11)
(14)
(8)
(19)
(11)
(8)
(8)
(11)
(9)
(8)
(11)
(10)
(8)
(8)
(14)
(13)
(10)
(16)
(9)
(30)
(11)
(11)
(10)
(14)
(23)
(8)
(9)
(12)
(11)
(10)
(8)
(8)
(9)
(20)
(17)
(12)
(10)
(8)
(18)
(13)
(17)
(11)
(9)
(29)
(10)
(9)
(13)
(11)
(8)
(29)
(13)
(13)
(9)
(11)
(40)
(8)
(10)
(12)
(14)
(8)
(13)
(16)
(9)
(12)
(8)
(9)
(11)
(8)
(9)
(40)
(10)
(9)
(20)
(17)
(8)
(24)
(13)
(10)
(24)
(9)
(18)
(20)
(9)
(9)
(8)
(8)
(29)
(15)
(8)
(73)
(9)
(38)
(8)
(23)
(10)
(24)
(9)
(12)
(9)
(8)
(10)
(12)
(11)
(8)
(22)
(9)
(13)
(10)
(16)
(8)
(9)
(13)
(17)
(11)
(8)
(12)
(15)
(9)
(9)
(13)
(9)
(8)
(20)
(14)
(32)
(9)
(16)
(10)
(10)
(10)
(12)
(8)
(9)
(33)
(16)
(8)
(10)
(8)
(11)
(13)
(14)
(21)
(10)
(15)
(8)
(8)
(12)
(8)
(15)
(12)
(18)
(9)
(12)
(13)
(13)
(23)
(11)
(15)
(11)
(9)
(8)
(8)
(13)
(25)
(13)
(17)
(8)
(13)
(11)
(13)
(11)
(9)
(10)
(8)
(10)
(21)
(13)
(21)
(23)
(25)
(8)
(9)
(11)
(11)
(15)
(10)
(13)
(10)
(9)
(19)
(14)
(10)
0 of 1000
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(4)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(2)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(13)
(1)
(1)
(7)
(1)
(16)
(14)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(33)
(1)
(2)
(106)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(4)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(68)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(8)
(4)
(1)
(3)
(6)
(5)
(2)
(1)
(11)
(1)
(2)
(3)
(1)
(7)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(6)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(12)
(1)
(3)
(1)
(1)
(3)
(1)
(1)
(116)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3941)
(6)
(1)
(1)
(2)
(11)
(10)
(1)
(1)
(41)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(14)
(1)
(1)
(1)
(4)
(20)
(1)
(7)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(5)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(13)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(65)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(33)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(21)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(425)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(6)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(13)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(3)
(4)
(2)
(5)
(1)
(2)
(3)
(2)
(3)
(9)
(2)
(2)
(2)
(2)
(9)
(2)
(7)
(4)
(2)
(2)
(5)
(2)
(12)
(12)
(2)
(7)
(4)
(2)
(3)
(2)
(3)
(4)
(4)
(2)
(5)
(7)
(4)
(2)
(5)
(7)
(2)
(9)
(2)
(2)
(8)
(2)
(2)
(2)
(4)
(9)
(3)
(3)
(2)
(2)
(5)
(9)
(4)
(4)
(2)
(2)
(5)
(4)
(2)
(3)
(3)
(9)
(4)
(4)
(6)
(4)
(2)
(3)
(2)
(6)
(2)
(11)
(2)
(3)
(2)
(2)
(2)
(3)
(10)
(4)
(2)
(8)
(2)
(15)
(2)
(2)
(20)
(2)
(3)
(6)
(2)
(2)
(5)
(2)
(13)
(11)
(2)
(24)
(2)
(3)
(3)
(7)
(2)
(3)
(3)
(3)
(2)
(9)
(2)
(14)
(2)
(7)
(3)
(4)
(3)
(2)
(3)
(9)
(5)
(9)
(50)
(8)
(3)
(13)
(3)
(3)
(2)
(4)
(3)
(9)
(5)
(3)
(2)
(2)
(2)
(15)
(9)
(5)
(4)
(2)
(5)
(4)
(5)
(4)
(5)
(5)
(11)
(4)
(12)
(5)
(2)
(2)
(7)
(5)
(3)
(2)
(5)
(2)
(2)
(3)
(2)
(3)
(2)
(2)
(149)
(7)
(2)
(2)
(3)
(3)
(3)
(3)
(2)
(6)
(2)
(3)
(3)
(10)
(2)
(16)
(2)
(7)
(9)
(6)
(4)
(7)
(5)
(4)
(11)
(3)
(4)
(13)
(17)
(2)
(24)
(2)
(2)
(4)
(8)
(7)
(11)
(8)
(5)
(3)
(13)
(4)
(17)
(6)
(9)
(2)
(22)
(2)
(2)
(6)
(3)
(9)
(3)
(2)
(4)
(15)
(3)
(4)
(3)
(8)
(15)
(6)
(2)
(23)
(2)
(2)
(4)
(5)
(5)
(24)
(2)
(4)
(2)
(7)
(2)
(2)
(9)
(3)
(2)
(9)
(6)
(11)
(5)
(15)
(4)
(2)
(3)
(5)
(6)
(2)
(118)
(5)
(18)
(3)
(2)
(7)
(125)
(2)
(3)
(2)
(5)
(7)
(2)
(3)
(2)
(4)
(6)
(6)
(3)
(3)
(2)
(3)
(2)
(10)
(12)
(4)
(2)
(3)
(3)
(4)
(9)
(2)
(2)
(2)
(5)
(6)
(4)
(2)
(2)
(13)
(2)
(4)
(2)
(2)
(2)
(4)
(3)
(9)
(2)
(4)
(2)
(2)
(2)
(7)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(4)
(3)
(3)
(3)
(4)
(12)
(4)
(2)
(5)
(6)
(5)
(2)
(3)
(14)
(4)
(2)
(2)
(2)
(2)
(2)
(14)
(7)
(7)
(3)
(2)
(3)
(2)
(2)
(2)
(44)
(183)
(2)
(88)
(115)
(2)
(8)
(16)
(10)
(5)
(2)
(14)
(180)
(2)
(3)
(3)
(6)
(93)
(2)
(2)
(2)
(4)
(317)
(7)
(11)
(2)
(6)
(8)
(2)
(3)
(26)
(80)
(2)
(2)
(22)
(3)
(2)
(36)
(30)
(10)
(4)
(3)
(6)
(2)
(3)
(4)
(3)
(2)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(4)
(2)
(2)
(4)
(2)
(3)
(2)
(2)
(2)
(2)
(4)
(3)
(2)
(5)
(2)
(2)
(4)
(2)
(2)
(2)
(4)
(15)
(3)
(3)
(2)
(14)
(2)
(2)
(6)
(15)
(13)
(4)
(2)
(3)
(5)
(2)
(2)
(5)
(8)
(2)
(4)
(2)
(3)
(2)
(3)
(7)
(2)
(2)
(4)
(4)
(2)
(4)
(2)
(2)
(2)
(2)
0 of 1000
(2)
(1)
(113)
(2)
(8)
(1)
(2910)
(5)
(2018)
(13)
(35)
(84)
(3)
(1)
(1)
(2)
(4)
(14)
(1)
(53)
(4075)
(2)
(4)
0 of 23
(1)
(2)
(15)
(33)
(13)
(1)
(8)
(2)
(2)
(4)
(5)
(25)
(1)
(7)
(2)
(180)
(1)
(113)
(2)
(3)
(7)
(1)
(3)
(10)
(11)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(168)
(159)
(1)
(1)
(1)
(1)
(20)
(1)
(28)
(1)
(2)
(23)
(2)
(1)
(1)
(1)
(1)
(1)
(23)
(8)
(1)
(2)
(3)
(1)
(6)
(1)
(19)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(3)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(12)
(1)
(1)
(1)
(2)
(1)
(16)
(1)
(1)
(3)
(1)
(20)
(1)
(5)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(2)
(2)
(2)
(1)
(871)
(2)
(1)
(11)
(1)
(3)
(6)
(1)
(1)
(1)
(87)
(4)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(2)
(1)
(1)
(14)
(3)
(53)
(1)
(4)
(1)
(1)
(1)
(8)
(17)
(1)
(1)
(1)
(1)
(7)
(1)
(8)
(266)
(1)
(7)
(1)
(1)
(3)
(201)
(2)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(2)
(2)
(39)
(1)
(14)
(13)
(1)
(5)
(1)
(2)
(11)
(1)
(1)
(177)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(4)
(1)
(7)
(1)
(1)
(1)
(4)
(68)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(39)
(2)
(1)
(1)
(5)
(3)
(12)
(315)
(1)
(1)
(1)
(1)
(28)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(468)
(3)
(6)
(42)
(3)
(12)
(5)
(1)
(4)
(10)
(1)
(1)
(20)
(1)
(8)
(1)
(1)
(1)
(3)
(2)
(15)
(14)
(8)
(2)
(18)
(1)
(112)
(1)
(1)
(1)
(1)
(4)
(5)
(24)
(1)
(1)
(9)
(3)
(76)
(1)
(307)
(1)
(1)
(1)
(31)
(161)
(12)
(1)
(174)
(3)
(3)
(10)
(7)
(25)
(1)
(1)
(1)
(4)
(23)
(42)
(1)
(1)
(1)
(1)
(111)
(1)
(1)
(1)
(1)
(213)
(18)
(1)
(1)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(4)
(1)
(1)
(1)
(1)
(4)
(32)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(13)
(3)
(96)
(1)
(1)
(2)
(4)
(5)
(209)
(1)
(2)
(3)
(1)
(1)
(127)
(9)
(7)
(3)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(204)
(1)
(1)
(272)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(55)
(1)
(1)
(1)
(1)
(1)
(5)
(265)
(12)
(5)
(3)
(11)
(1)
(8)
(3)
(1)
(1)
(1)
(3)
(1)
(306)
(3)
(1)
(131)
(2)
(1)
(163)
(1)
(1)
(1)
(77)
(4)
(3)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(3)
(3)
(112)
(1)
(1)
(9)
(2)
(27)
(34)
(2)
(1)
(1)
(3)
(1)
(18)
(1)
(5)
(3)
(3)
(60)
(1)
(237)
(2)
(1)
(187)
(2)
(1)
(5)
(1)
(500)
(1)
(6)
(2)
(16)
(1)
(7)
(5)
(156)
(1)
(1)
(1)
(6)
(3)
(9)
(4)
(31)
(1)
(1)
(4)
(1)
(248)
(1)
(45)
(1)
(2)
(4)
(10)
(8)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(558)
(114)
(1)
(1)
(4)
(10)
(1)
(1)
(267)
(1)
(57)
(80)
(241)
(256)
(318)
(52)
(45)
(51)
(88)
(72)
(1)
(1)
(1)
(1)
(1)
(3)
(6)
(8)
(31)
(8)
(7)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(300)
(1)
(1)
(13)
(10)
(2)
(27)
(1)
(1)
(1)
(1)
(1)
(18)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(19)
(1)
(1)
(1)
(5)
(16)
(1)
(2)
(1)
(154)
(1)
(1)
(1)
(5)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(90)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(3)
(1)
(4)
(1)
(4)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(18)
(13)
(1)
(14)
(1)
(1)
(13)
(11)
(1)
(2)
(1)
(116)
(46)
(8)
(2)
(1)
(4)
(9)
(4)
(20)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(2)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(2)
(22)
(24)
(1)
(1)
(1)
(3)
(1)
(18)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(185)
(1)
(1)
(481)
(22)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(11)
(8)
(1)
(1)
(1)
(7)
(1)
(1)
(130)
(1)
(24)
(1)
(1)
(67)
(7022)
(1)
(11)
(1)
(1)
(5)
(11)
(154)
(1)
(1)
(11)
(79)
(1)
(1)
(3)
(31)
(3)
(1)
(4)
(215)
(4)
(2)
(1)
(1)
(30)
(2)
(1)
(390)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(256)
(1)
(1)
(195)
(1)
(1)
(2)
(1)
(45)
(1)
(3)
(9)
(6)
(8)
(9)
(1)
0 of 772
(1)
(55)
(9)
(2)
(2)
(25)
(294)
(2)
(2)
(2)
(3)
(1)
(5)
(27)
(1)
(3)
(5)
(14)
(61)
(10)
(1)
(2)
(5)
(1)
(729)
(2)
(2776)
(5)
(5)
(37)
(1)
(15)
(1)
(7)
(3)
(16)
(27)
(1)
(108)
(2)
(383)
(52)
(1)
(1)
(1)
(1)
(2027)
(1)
(5)
(1)
(8)
(366)
(4)
(3)
(50)
(3)
0 of 56
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(8)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(2)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
0 of 794
(82)
(4)
(1)
(6)
0 of 4
Showing 901 - 920 of 9537 results
  • Tuberculosis United States 2021
    Tuberculosis — United States, 2021
    Filardo, Thomas D. ;
    Feng, Pei-Jean
    3 25 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    During 1993-2019, the incidence of Tuberculosis (TB) in the United States decreased steadily; however, during the later years of that period the annual rate of decline slowed (1) until 2020 when a substantial decline (19.9%) was observed. This sharp decrease in TB incidence might have been related to multiple factors coinciding with the COVID-19 pa ...
    Supporting Files Public Domain
  • Supplementary Table 2 Use of AtHome COVID19 Testing United States August 23 2021March 12 2022
    Supplementary Table 2. Use of At-Home COVID-19 Testing — United States, August 23, 2021–March 12, 2022
    Centers for Disease Control and Prevention (U.S.)
    03/25/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Notes From the Field First Reports of Locally Transmitted Seoul Hantavirus Infection District of Columbia May 2018December 2018
    Notes From the Field: First Reports of Locally Transmitted Seoul Hantavirus Infection — District of Columbia, May 2018–December 2018
    Ravi-Caldwell, Nivedita ;
    Iyengar, Preetha
    2022/03/24 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination Worldwide 20002020
    Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination — Worldwide, 2000–2020
    Kanu, Florence A. ;
    Yusuf, Nasir
    3 18 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Maternal and neonatal tetanus (MNT)* remains a major cause of neonatal Mortality with an 80%-100% case-fatality rate among insufficiently vaccinated mothers after unhygienic deliveries, especially in low-income countries (1). In 1989, the World Health Assembly endorsed elimination| of neonatal tetanus; the activity was relaunched in 1999 as the MNT ...
    Supporting Files Public Domain
  • The Advisory Committee on Immunization Practices Recommendation for Use of Moderna COVID19 Vaccine in Adults Aged 18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID19 Vaccines United States February 2022
    The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022
    Wallace, Megan ;
    Moulia, Danielle
    3 18 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The mRNA-1273 (Moderna) COVID-19 vaccine is a lipid nanoparticle-encapsulated, nucleoside-modified mRNA vaccine encoding the stabilized prefusion spike glycoprotein of SARS-CoV-2, the Virus that causes COVID-19. During December 2020, the vaccine was granted Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA), and the Advisor ...
    Supporting Files Public Domain
  • Reported Cases of EndStage Kidney Disease US 20002019
    Reported Cases of End-Stage Kidney Disease — U.S. 2000–2019
    Burrows, Nilka Ríos ;
    Koyama, Alain
    3 18 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    End-stage kidney disease (ESKD) (kidney failure requiring dialysis or transplantation) is a costly and disabling condition that often results in premature death (1). During 2019, Medicare fee-for-service expenditures for ESKD were $37.3 billion, accounting for approximately 7% of Medicare paid claims costs (1). Diabetes and hypertension remain the ...
    Supporting Files Public Domain
  • QuickStats Rate of Unintentional Traumatic Brain InjuryRelated Deaths Among Persons Aged 19 Years by Age Group and Sex National Vital Statistics System US US 20182020
    QuickStats: Rate of Unintentional Traumatic Brain Injury–Related Deaths Among Persons Aged ≤19 Years, by Age Group and Sex — National Vital Statistics System (U.S.), U.S. 2018–2020
    Spencer, Merianne Rose ;
    Garnett, Matthew F.
    3 18 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    During 2018–2020, death rates for unintentional traumatic brain injury among persons aged ≤19 years were higher for males than for females in each age group. Rates were highest for males (6.1 per 100,000) and females (2.9) among persons aged 15–19 years. Rates were lowest for males and females aged 5–9 years (1.1 and 0.8, respectively) and for male ...
    Supporting Files Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 71 No 11 March 18 2022
    MMWR. Morbidity and Mortality Weekly Report, Vol. 71, No. 11, March 18, 2022
    Centers for Disease Control and Prevention (U.S.)
    03/18/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Tobacco Product Use Among Adults — U.S. 2020 / Monica E. Cornelius; Caitlin G. Loretan; Teresa W. Wang; Ahmed Jamal et al.-- Progress Toward Achieving and Sustaining Maternal and Neonatal TetanuElimination — Worldwide, 2000–2020 / Florence A. Kanu; Nasir Yusuf; Modibo Kassogue; Bilal Ahmed; Rania A. Tohme -- Reported Cases of End-Stage Kidney Disea ...
    Public Domain
  • Hospitalization of Infants and Children Aged 04 Years with LaboratoryConfirmed COVID19 COVIDNET 14 States March 2020February 2022
    Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022
    Marks, Kristin J. ;
    Whitaker, Michael
    3 18 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The B.1.1.529 (Omicron) Variants of SARS-CoV-2, the Virus that causes COVID-19, has been the predominant circulating Variants in the U.S. since late December 2021.* Coinciding with increased Omicron circulation, COVID-19-associated hospitalization rates increased rapidly among infants and children aged 0-4 years, a group not yet eligible for vaccin ...
    Supporting Files Public Domain
  • COVID19 MRNA Vaccines Help Protect Against the Most Serious COVID19 Outcomes Even During Omicron
    COVID-19 MRNA Vaccines Help Protect Against the Most Serious COVID-19 Outcomes, Even During Omicron
    Centers for Disease Control and Prevention (U.S.)
    March 18, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Adults who received 3 doses of COVID-19 vaccine were 94% less likely to be put on a ventilator or die from COVID-19 compared to adults who were not vaccinatedllustration accompanying: Tenforde MW, Self WH, Gaglani M, et al. Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, ...
    Public Domain
  • Effectiveness of 2Dose BNT162b2 Pfizer BioNTech mRNA Vaccine in Preventing SARSCoV2 Infection Among Children Aged 511 Years and Adolescents Aged 1215 Years PROTECT Cohort July 2021February 2022
    Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022
    Fowlkes, Ashley L. ;
    Yoon, Sarang K.
    3 18 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The BNT162b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine was recommended by CDC's Advisory Committee on Immunization Practices for persons aged 12-15 years (referred to as adolescents in this report) on May 12, 2021, and for children aged 5-11 years on November 2, 2021 (1-4). Real-world data on vaccine effectiveness (VE) in these age groups are needed, ...
    Supporting Files Public Domain
  • COVID19associated Hospitalizations Among Adults During SARSCoV2 Delta and Omicron Variants Predominance by Raceethnicity and Vaccination Status COVIDNET 14 States July 2021January 2022
    COVID-19–associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variants Predominance, by Race/ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022
    Taylor, Christopher A. ;
    Whitaker, Michael
    March 18, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? SARS-CoV-2 infections can result in COVID-19–associated hospitalizations, even among vaccinated persons.What is added by this report? In January 2022, unvaccinated adults and those vaccinated with a primary series, but no booster or additional dose, were 12 and three times as likely to be hospitalized, respec ...
    Supporting Files Public Domain
  • Effectiveness of MRNA Vaccination in Preventing COVID19associated Invasive Mechanical Ventilation and Death United States March 2021January 2022
    Effectiveness of MRNA Vaccination in Preventing COVID-19–associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
    Tenforde, Mark W. ;
    Self, Wesley H.
    March 18, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? COVID-19 mRNA vaccines provide protection against COVID-19 hospitalization among adults. However, how well mRNA vaccines protect against the most severe outcomes of COVID-19–related illness, including use of invasive mechanical ventilation (IMV) or death, is uncertain.What is added by this report? Receiving 2 ...
    Supporting Files Public Domain
  • During the Peak of Omicron COVID19 Hospitalization Rates in Black Adults Were Nearly 4x as High as Rates Among White Adults
    During the Peak of Omicron, COVID-19 Hospitalization Rates in Black Adults Were Nearly 4x as High as Rates Among White Adults
    Centers for Disease Control and Prevention (U.S.)
    March 18, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Improving access to and confidence in vaccinations is needed to reduce this disparity.llustration accompanying: Taylor CA, Whitaker M, Anglin O, et al. COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022. M ...
    Public Domain
  • Tobacco Product Use Among Adults United States 2020
    Tobacco Product Use Among Adults - United States, 2020
    Cornelius, Monica E. ;
    Loretan, Caitlin G.
    2022/03/18 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Although cigarette smoking has declined over the past several decades, a diverse landscape of combustible and noncombustible tobacco products has emerged in the United States (1-4). To assess recent national estimates of commercial tobacco product use among U.S. adults aged ≥18 years, CDC analyzed data from the 2020 National Health Interview Survey ...
    Supporting Files Public Domain
  • Hospitalization of Infants and Children Aged 04 Years with Laboratoryconfirmed COVID19 COVIDNET 14 States March 2020February 2022
    Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022
    Marks, Kristin J. ;
    Whitaker, Michael
    March 15, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? COVID-19 can cause severe illness in infants and children, including those aged 0–4 years who are not yet eligible for COVID-19 vaccination.What is added by this report? During Omicron Variants predominance beginning in late December 2021, U.S. infants and children aged 0–4 years were hospitalized at approxim ...
    Supporting Files Public Domain
  • COVID19 Hospitalization Rates Among Children Ages 4 and Younger Were 5x as High During the Peak of Omicron Compared with Delta
    COVID-19 Hospitalization Rates Among Children Ages 4 and Younger Were 5x as High During the Peak of Omicron Compared with Delta.
    Centers for Disease Control and Prevention (U.S.)
    March 15, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Get vaccinated to help protecty yourself and those too young to be vaccinated.llustration accompanying: Marks KJ, Whitaker M, Agathis NT, et al. Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022. MMWR Morb Mortal Wkly Rep. ePub: 15 March 2022.mm7111e2_Pediatric ...
    Public Domain
  • Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDCSponsored Investigational New Drug Program for Treatment of Chagas Disease US 20012021
    Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — U.S. 2001–2021
    Abbott, Andrew ;
    Montgomery, Susan P.
    3 11 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Chagas disease, or American trypanosomiasis, is caused by the parasite Trypanosoma cruzi. Chagas disease is endemic in rural areas of Latin America, but T. cruzi, triatomine vectors, infected mammalian reservoir hosts, and rare cases of autochthonous vector borne Transmission have been reported in the U.S. (1). Possible modes of Transmission includ ...
    Supporting Files Public Domain
  • SARSCoV2 Incidence in K12 School Districts with MaskRequired Versus MaskOptional Policies Arkansas AugustOctober 2021
    SARS-CoV-2 Incidence in K–12 School Districts with Mask-Required Versus Mask-Optional Policies — Arkansas, August–October 2021
    Donovan, Catherine V. ;
    Rose, Charles
    3 11 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Masks are effective at limiting Transmission of SARS-CoV-2, the Virus that causes COVID-19 (1), but the impact of policies requiring masks in school settings has not been widely evaluated (2-4). During fall 2021, some school districts in Arkansas implemented policies requiring masks for students in kindergarten through grade 12 (K-12). To identify ...
    Supporting Files Public Domain
  • Evaluation of Serologic CrossReactivity Between Dengue Virus and SARSCoV2 in Patients with Acute Febrile Illness United States and Puerto Rico April 2020March 2021
    Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness — United States and Puerto Rico, April 2020–March 2021
    Munoz-Jordan, Jorge ;
    Cardona, Jaime
    3 11 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The Diagnosis of dengue disease, caused by the dengue Virus (DENV) (a flaviVirus), often requires serologic tTesting during acute and early convalescent phases of the disease. Some symptoms of DENV infection, such as nonspecific fever, are similar to those caused by infection with SARS-CoV-2, the Virus that causes COVID-19. In studies with few COVI ...
    Supporting Files Public Domain
901 - 920 / 9537
 Was this page helpful?
 Found an issue?
Send us an email at: publishinghd@cdc.gov